The Paragard IUD lawsuits in 2026 cover people whose Paragard T380A copper birth-control device broke during removal and left a fragment in the body. Eligibility turns on proof of breakage plus treatment, and filing deadlines depend on state law and can be as short as two years. Paragard is a copper IUD, a T-shaped device placed in the uterus for long-term pregnancy prevention. Plaintiffs allege the device can fracture during removal, leaving fragments embedded in the uterus that may require imaging, hysteroscopy, or other surgery, according to DrugWatch in its DrugWatch lawsuit summary.
Official resources:
- Explore the official data from Uscourts — Use this primary source to review the underlying data.
- Explore the official data from FDA — Use this primary source to review the underlying data.
Table of Contents
- Who may qualify to file?
- What evidence carries weight?
- Where do the federal cases stand?
- What deadlines control a claim?
Who may qualify to file?
Most claimants share three facts: a Paragard T380A insertion, breakage on removal with a retained fragment or organ injury, and medical records linking insertion, breakage, and treatment. That pattern comes from current eligibility guides for Paragard claims.
A useful self-check looks like this: Normal removal without breakage, expulsion without fracture, or symptoms without a retained fragment generally do not fit this litigation. Prior Teva implants and later CooperSurgical implants can involve different defendants because CooperSurgical completed its acquisition of Paragard rights from Teva on November 1, 2017.
- Had a Paragard T380A, not a hormonal IUD
- Provider noted breakage or a missing arm during removal
- Imaging or a procedure confirmed a retained piece
- Records show follow-up care, referral, hysteroscopy, or surgery
- Insertion, removal, and treatment dates are documented
What evidence carries weight?
Treatment records matter more than symptoms alone. Keep operative notes from insertion and removal, ultrasound or X-ray reports, pathology reports, referral letters, and bills for follow-up visits. A short written timeline also helps: insertion date, removal attempt date, when pain or bleeding began, and each later procedure. The label issue is central.
The FDA-approved 2019 Paragard label warns that partial penetration or embedment can make removal difficult and states that breakage of an embedded device during nonsurgical removal has been reported, as shown in the FDA drug label. That warning shapes arguments about notice, removal risk, and medical causation. Save the device fragment report when available, plus pharmacy and clinic records showing the product was Paragard T380A. Do not discard discharge papers that say "fragments retained," "incomplete removal," or "refer to surgery." Those phrases connect the removal event to later care.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Where do the federal cases stand?
Federal cases are centralized as In re: Paragard IUD Products Liability Litigation, MDL 2974 in the Northern District of Georgia. The U.S. Judicial Panel on Multidistrict Litigation reported 3,926 pending actions in its March 2026 MDL statistics. Bellwether trials are test cases selected for early jury verdicts. A federal Atlanta jury returned a defense verdict for Teva in the first bellwether trial in February 2026, rejecting failure-to-warn and defective-design claims, according to Reuters trial coverage.
One defense verdict does not end the MDL, but it can affect settlement leverage and trial strategy. No global Paragard settlement had been reached as of 2026. The second bellwether case, Robere v. Teva, was rescheduled to begin April 12, 2027 after its September 2026 date was vacated. New claims can still be filed while earlier cases move toward trial.
What deadlines control a claim?
Filing deadlines vary by state, most commonly two to three years from injury or discovery. That range means 2022-2023 injuries in two-year states may already be time-barred, making prompt legal review the practical step. The clock may start at removal, at discovery of a retained fragment, or at a later surgery, depending on state rules. Tolling for minors, fraud concealment, and out-of-state defendants also varies.
Keep every dated record because the exact start date often decides whether a case survives. Ask a lawyer promptly for the deadline in the state where the device was implanted or removed. Bring insertion and removal dates, imaging dates, and proof of where care occurred. Waiting for MDL news does not pause a personal filing deadline.
You Might Also Like
- Pharmaceutical Lawsuit Settlement Guide 2026: Eligibility, Evidence, and Deadlines
- Asbestos Guide 2026: Eligibility, Evidence, and Deadlines
- AFFF Settlement Update Guide 2026: Eligibility, Evidence, and Deadlines